三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
卡度尼利开发情况
卡度尼利开发情况
其它
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：102KB
图片尺寸：1155*830
同报告图片
/
4
5Lul5LiL5piv5qC55o2u5oKo5o+Q5L6b55qE5Zu+54mH55Sf5oiQ55qE5pWw5o2u6KGo5qC877yaCgp8IOmihuWfnyAgICAgfCDnlKjoja/mlrnlvI8gICAgICAgfCDpgILlupTnl4cgICAgICAgICAgICAgICAgICAgICAgIHwg6L+b5bqmICAgICAgICAgICAgICAgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCDlrqvpoojnmYwgICB8IOWNleiNryAgICAgICAgICAgfCAyTC8zTCDlrqvpoojnmYwgICAgICAgICAgICAgICAgIHwgMjAyMjA2IOiOt+aJuSAgICAgICB8Cnwg5a6r6aKI55mMICAgfCAr5YyW55aXwrHotJ3kvJDnj6AgICB8IDFMIOWuq+miiOeZjCAgICAgICAgICAgICAgICAgICAgfCDlhbPplK4vSUlJ5pyf77yI5YWl57uE5a6M5oiQ77yJIHwKfCDog4PnmYwgICAgIHwgK1hFTE9Y5YyW55aX5pa55qGIIHwgMUwg6IODL+iDg+mjn+euoee7k+WQiOmDqOiFuueZjCAgICAgICB8IOWFs+mUri9JSUnmnJ/vvIjlhaXnu4TlrozmiJDvvIkgfAp8IOiCneeZjCAgICAgfCDljZXoja8gICAgICAgICAgIHwg6IKd55mM5pyv5ZCO6L6F5Yqp5rK755aXICAgICAgICAgICAgIHwg5YWz6ZSuL0lJSeacn++8iOWFpee7hOS4re+8iSAgfAp8IOiCuueZjCAgICAgfCAr5YyW55aXICAgICAgICAgIHwgMUwgUEQtTDEg6Zi05oCn55qE6Z2e5bCP57uG6IOe6IK655mMICB8IOWFs+mUri9JSUnmnJ/vvIjlkK/liqjvvIkgICB8CgrotYTmlpnmnaXmupDvvJrlurfmlrnnlJ/niannvZHnq5nvvIzlm73ogZTor4HliLjnoJTnqbbmiYA=
fOW5tOS7vQl8MjAxNgl8MjAxNwl8MjAxOAl8MjAxOQl8MjAyMEUJfDIwMjFFCXwyMDIyRQl8MjAyM0UJfDIwMjRFCXwyMDI1RQl8MjAyNkUJfDIwMjdFCXwyMDI4RQl8MjAyOUUJfDIwMzBFCXwKfC0tLQl8LS0tCXwtLS0JfC0tLQl8LS0tCXwtLS0JfC0tLQl8LS0tCXwtLS0JfC0tLQl8LS0tCXwtLS0JfC0tLQl8LS0tCXwtLS0JfC0tLQl8CnzmgqPogIXkurrmlbDvvIjljYPkurrvvIkJfDQxNi4wCXw0MjMuNgl8NDMxLjkJfDQ0MC44CXw0NDkuOQl8NDU5LjQJfDQ2OC45CXw0NzguOQl8NDg4LjYJfDQ5OC4wCXw1MDcuMgl8NTE2LjkJfDUyNi45CXw1MzcuMgl8NTQ3LjcJfA==
fCDkuqflk4EgfCDpgILlupTnl4cgfCBJ5pyfIHwgSUnmnJ8gfCBJSUnmnJ8gfCDlpIfms6ggfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQ29sdW12aSB8IDNMK0RMQkNMIHwgIHwgIHwgIHwg576O5Zu9L+asp+a0suW3suaJueWHhiB8CnwgQ29sdW12aStHZW1PeCB8IDJMK0RMQkNMKOaXoOazlei/m+ihjOmAoOihgOW5sue7huiDnuenu+akjeeahOaCo+iAhSkgfCAgfCAgfCAgfCAyMDI05pWw5o2u6K+75Ye6IHwKfCBDb2x1bXZpK0NEMTl4NC0xQkIgfCDlpI3lj5Ev6Zq+5rK755qETkhMIHwgIHwgIHwgIHwgIHwKfCBDb2x1bXZpK0NEMTl4Q0QyOCB8IOWkjeWPkS/pmr7msrvnmoROSEwgfCAgfCAgfCAgfCAgfAp8IENvbHVtdmkrUG9saXZ5K1ItQ0hQIHwgMUwgRExCQ0wgfCAgfCAgfCAgfCAyMDIz5bm05byA5aeLM+acnyB8CnwgTHVuc3VuaW8gfCAzTCtGTCB8ICB8ICB8ICB8IOe+juWbvS/mrKfmtLLlt7Lmibnlh4YgfAp8IEx1bnN1bmlvK1BvbGl2eSB8IDJMK0RMQkNMKOaXoOazlei/m+ihjOmAoOihgOW5sue7huiDnuenu+akjeeahOaCo+iAhSkgfCAgfCAgfCAgfCAyMDI05bm06K+75Ye6IHwKfCBMdW5zdW5pbyvmnaXpgqPluqbog7ogfCAyTCtGTCB8ICB8ICB8ICB8IDIwMjTlubTkuK3mnJ/mlbDmja7liIbmnpAgfAp8IEx1bnN1bmlvIHwgci9yIENMTCB8ICB8ICB8ICB8ICB8CnwgTHVuc3VuaW8gfCAxTCBETEJDTO+8iOiAgeS6uu+8iSB8ICB8ICB8ICB8ICB8CnwgTHVuc3VuaW8rUG9saXZ5IHwgMUwgRExCQ0zvvIjogIHkurrvvIkgfCAgfCAgfCAgfCAgfAoK6LWE5paZ5p2l5rqQ77ya572X5rCP5YWs5ZGK77yM5Zu96IGU6K+B5Yi456CU56m25omA77yI5rOo77yaUG9saXZ55rOK5rSb5aal54+g5Y2V5oqX77yMYWRj6I2v54mp77yM6Z225ZCRQ0Q3OWLvvJtHZW1PeO+8jOWQieilv+S7lua7qCvlpaXmspnliKnpk4LvvIk=
所属报告：
医药生物行业：眼科、肺癌中展现优势双抗商业化价值凸显-231227（31页）.pdf
打包全文图表
相关数据
阿布昔替尼的应答率及应答时间优于度普利尤单抗
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
收藏
行业数据
2024-12-12
原图定位
查看详情
度普利尤单抗与乌帕替尼、阿布西替尼安全性数据对比
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
收藏
行业数据
2024-12-05
原图定位
查看详情
2022H2-2023H2卡度尼利单抗销售额（亿元）
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
收藏
行业数据
2024-10-21
原图定位
查看详情
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗在全人群优于贝伐和化疗
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗与纳武利尤单抗联合伊匹木单抗相比安全性更优
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
收藏
其它
2024-07-10
原图定位
查看详情
开坦尼®(卡度尼利,PD-1/CTLA-4)临床研究计划
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗肝癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗胃癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
JAK1抑制剂（乌帕替尼）疗效优于度普利尤单抗
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
收藏
其它
2024-02-27
原图定位
查看详情
卡度尼利销售额（百万元）
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOaXtumXtCAgICAgICB8IOWNoeW6puWwvOWIqemUgOWUrumine+8iOeZvuS4h+WFg++8iSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMkgyICAgICB8IDU0Ni4zICAgICAgICAgICAgICAgICAgICB8CnwgMjAyM0gxICAgICB8IDYwNiAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlurfmlrnnlJ/niannvZHnq5nvvIzlm73ogZTor4HliLjnoJTnqbbmiYA=
收藏
其它
2023-12-29
原图定位
查看详情
图13.乌帕替尼与度普利尤单抗头对头研究EASI-100应答率与NRS对比
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
收藏
行业数据
2023-08-02
原图定位
查看详情
图12.乌帕替尼与度普利尤单抗头对头研究EASI-75与EASI-90应答率对比
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
收藏
行业数据
2023-08-02
原图定位
查看详情
图11.阿布昔替尼与度普利尤单抗头对头研究EASI-75应答率对比
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
收藏
行业数据
2023-08-02
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
康方生物的卡度尼利单抗（PD-1XCTLA-4）已经成功商业化，为首个商业化的国产双特异性抗体，上市首年(2022H2+2023H1)累计销售额达到 11.5 亿。已批准适应症为 2L/3L复发或转移性宫颈癌患者。目前处在关键/III期阶段的适应症包括 1L宫颈癌、1L胃癌、肝癌术后辅助治疗、1L PD-L1表达阴性的非小细胞肺癌。预计后续 1线适应症和术后辅助适应症上市后将会大幅拓展其使用场景。
其它
原图定位
当前图表所属：
医药生物行业：眼科、肺癌中展现优势双抗商业化价值凸显-231227（31页）.pdf
多发性骨髓瘤患病人数（千人）
罗氏两个CD20xCD3双抗的拓展思路
DLBCL的标准治疗
DLBCL和FL为B细胞非霍奇金淋巴瘤的主要亚型
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2024-12-12
原图定位
微信扫码登录
手机快捷登录
账号登录
